Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome.


Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
03 2022
Historique:
received: 31 12 2021
revised: 01 02 2022
accepted: 05 02 2022
pubmed: 10 2 2022
medline: 7 4 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

To assess associations between gingival crevicular fluid (GCF) markers in patients with metabolic syndrome, with or without concomitant periodontitis. A total of 95 patients with Metabolic Syndrome (MetS) had a periodontal examination and gingival crevicular fluid samples taken. Proteomic analysis of gingival crevicular fluid (GCF) was carried out by Human XL Cytokine protein arrays in 12 selected patients, followed by multiplex ELISA of 11 analytes in 95 participants. Increased levels of Aggrecan, IL-6 and IL-8 were found in patients with periodontal health compared with moderate and severe periodontitis. The inverse stepwise association between severity of periodontitis and reduced Aggrecan levels was also observed at adjusted linear regression analysis. Diagnosis of diabetes was associated with higher GCF levels of IL-8 and MMP-8. Diabetes may affect GCF levels of cytokines, irrespective of periodontal status. Periodontal status may be associated with Aggrecan levels in the GCF of patients affected by metabolic syndrome. Investigation of GCF biomarkers may potentially help have diagnostic potential in patients with MetS.

Identifiants

pubmed: 35139411
pii: S0300-5712(22)00122-1
doi: 10.1016/j.jdent.2022.104065
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104065

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Luigi Nibali (L)

Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, United Kingdom. Electronic address: luigi.nibali@kcl.ac.uk.

Abish Stephen (A)

Centre for Immunobiology & Regenerative Medicine and Centre for Oral Clinical Research, Institute of Dentistry, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom.

Eleni Hagi-Pavli (E)

Centre for Immunobiology & Regenerative Medicine and Centre for Oral Clinical Research, Institute of Dentistry, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom.

Robert Allaker (R)

Centre for Immunobiology & Regenerative Medicine and Centre for Oral Clinical Research, Institute of Dentistry, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom.

Antonino Di Pino (AD)

Department of Clinical and Experimental Medicine, Ospedale Garibaldi-Nesima, University of Catania, Catania, Italy.

Valentina Terranova (V)

Department of Clinical and Experimental Medicine, Ospedale Cannizzaro, University of Catania, Catania, Italy.

Marcella Pisano (M)

Department of Clinical and Experimental Medicine, Ospedale Cannizzaro, University of Catania, Catania, Italy.

Salvatore Di Marca (SD)

Department of Clinical and Experimental Medicine, Ospedale Cannizzaro, University of Catania, Catania, Italy.

Viviana Ferrara (V)

Department of Clinical and Experimental Medicine, Ospedale Garibaldi-Nesima, University of Catania, Catania, Italy.

Roberto Scicali (R)

Department of Clinical and Experimental Medicine, Ospedale Garibaldi-Nesima, University of Catania, Catania, Italy.

Mauro Giordano (M)

Universita' degli studi della Campania Luigi Vanvitelli, Dipartimento Scienze Mediche e Chirurgiche avanzate (DAMSS), Caserta, Italy.

Francesco Purrello (F)

Department of Clinical and Experimental Medicine, Ospedale Garibaldi-Nesima, University of Catania, Catania, Italy.

Nikolaos Donos (N)

Centre for Immunobiology & Regenerative Medicine and Centre for Oral Clinical Research, Institute of Dentistry, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom.

Lorenzo Malatino (L)

Department of Clinical and Experimental Medicine, Ospedale Cannizzaro, University of Catania, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH